Larry Radican Selected Research

Larry Radican Research Topics

26	Type 2 Diabetes Mellitus (MODY) 12/2019 - 04/2010
7	Hypoglycemia (Reactive Hypoglycemia) 11/2019 - 07/2011
2	Dementia (Dementias) 01/2021 - 11/2019
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 04/2010
2	Weight Gain 10/2017 - 11/2010
2	Heart Failure 03/2015 - 01/2013
1	Overactive Urinary Bladder (Overactive Bladder) 01/2021
1	Cognitive Dysfunction 01/2021
1	Infections 11/2019
1	Syncope (Fainting) 01/2018
1	Unconsciousness (Loss of Consciousness) 01/2018
1	Albuminuria 09/2016
1	Hyperglycemia 11/2012
1	Body Weight (Weight, Body) 08/2012
1	Obesity 11/2010
1	Chronic Renal Insufficiency 07/2010
1	Insulin Resistance 06/2009
1	Phobic Disorders (Phobia) 06/2009
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2006

13	Hypoglycemic Agents (Hypoglycemics)IBA 09/2015 - 07/2010
7	Sitagliptin Phosphate (Januvia)FDA Link 01/2018 - 04/2010
6	Metformin (Glucophage)FDA LinkGeneric 12/2019 - 07/2010
3	Hemoglobins (Hemoglobin)IBA 12/2019 - 01/2016
3	Glucose (Dextrose)FDA LinkGeneric 10/2017 - 01/2013
3	Insulin (Novolin)FDA Link 06/2017 - 06/2009
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2013 - 05/2011
2	CreatinineIBA 09/2016 - 07/2010
1	Muscarinic AntagonistsIBA 01/2021
1	Cholinergic Antagonists (Anticholinergics)IBA 01/2021
1	Long-Acting Insulin (Insulin, Long Acting)FDA Link 11/2019
1	CarbohydratesIBA 01/2018
1	AlbuminsIBA 09/2016
1	glimepiride (Amarel)FDA LinkGeneric 06/2011
1	Gliclazide (Diamicron)IBA 06/2011
1	Glyburide (Glibenclamide)FDA LinkGeneric 06/2011
1	Antihypertensive Agents (Antihypertensives)IBA 07/2010
1	2,4-thiazolidinedione (thiazolidinedione)IBA 07/2010
1	LipidsIBA 07/2010
1	Exenatide (Byetta)FDA Link 04/2010
1	Glucagon-Like Peptide-1 ReceptorIBA 04/2010
1	IncretinsIBA 04/2010
1	1,1,1-trichloroethaneIBA 01/2006
1	Gasoline (Diesel Fuel)IBA 01/2006
1	HydrocarbonsIBA 01/2006
1	Trichloroethylene (Trichloroethene)IBA 01/2006